1133P Additional practice-informing adverse event patterns and management in the KRYSTAL-1 phase II study of adagrasib (MRTX849) in patients with KRASG12C-mutated NSCLC

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 33; pp. S1068 - S1069
Main Authors	Zhang, J., Leventakos, K., Leal, T.A., Pennell, N., Barve, M., Paulson, A.S., Bazhenova, L., Johnson, M.L., Chao, R.C., Velastegui, K., Qian, C., Bleker, W., Spira, A.
Format	Journal Article
Language	English
Published	01.09.2022
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2022.07.1257